March 18, 2020
The Ministry of Health, Labor and Welfare (MHLW) on March 17 granted orphan drug designation for seven drugs including Zenyaku Kogyo/Chugai Pharmaceutical’s anticancer drug Rituxan (rituximab) for two indications. Rituxan newly obtained the orphan status for the treatment of “systemic...read more